Company: ACHV
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0000950170-25-036831
Chunk: 6

Company: ACHIEVE LIFE SCIENCES, INC.
Filing Date: 2025-03-11
Form: 10-K
Item: Item 15
Chunk 6
---
    Filing Date

    and between Achieve Life Sciences, Inc. and John Bencich ††

    10.16
     
    Amended and Restated Employment Agreement, dated September 27, 2022, by and between Achieve Life Sciences, Inc. and Cindy Jacobs ††
     
    10-K
     
    033-80623
     
    10.26
     
    March 16, 2023

    10.17
     
    Separation and Release Agreement, dated August 26, 2024, between Achieve Life Sciences, Inc. and John Bencich
     
    10-Q
     
    033-80623
     
    10.3
     
    November 7, 2024

    10.18
     
    Executive Employment Agreement, dated August 26, 2024, between Achieve Life Sciences, Inc. and Thomas B. King
     
    10-Q
     
    033-80623
     
    10.4
     
    November 7, 2024

    10.19
     
    Executive Employment Agreement, dated December 5, 2024, between Achieve Life Sciences, Inc. and Mark K. Oki

    X

    10.20
      
    Exclusive License Agreement, by and between Sopharma Joint Stock Company and Extab Corporation, dated May 26, 2009*
      
    S-4/A
      
    333-216961
      
    10.21
      
    May 3, 2017

    10.21
      
    Commercial Agreement on Supply of Pharmaceutical Products, by and between Sopharma AD and Extab Corporation, dated February 1, 2010*
      
    S-4/A
      
    333-216961
      
    10.23
      
    May 3, 2017

    10.22
     
    Variation of Contract, by and between Sopharma AD and Extab Corporation, dated May 14, 2015*
     
    S-4/A
     
    333-216961
     
    10.22
     
    May 3, 2017

    10.23
      
    Variation of Contract, by and between Sopharma AD and Extab Corporation, dated May 14, 2015*